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Brain volume and thickness abnormalities have been 
reported in first-episode psychosis (FEP). However, it is 
unclear if and how they are modulated by brain develop-
mental stage (and, therefore, by age at FEP as a proxy). 
This is a multicenter cross-sectional case-control brain 
magnetic resonance imaging (MRI) study. Patients with 
FEP (n = 196), 65.3% males, with a wide age at FEP span 
(12–35 y), and healthy controls (HC) (n = 157), matched 
for age, sex, and handedness, were scanned at 6 sites. Gray 
matter volume and thickness measurements were gener-
ated for several brain regions using FreeSurfer software. 
The nonlinear relationship between age at scan (a proxy 
for age at FEP in patients) and volume and thickness mea-
surements was explored in patients with schizophrenia 
spectrum disorders (SSD), affective psychoses (AFP), and 
HC. Earlier SSD cases (ie, FEP before 15–20 y) showed 
significant volume and thickness deficits in frontal lobe, 
volume deficits in temporal lobe, and volume enlargements 
in ventricular system and basal ganglia. First-episode AFP 
patients had smaller cingulate cortex volume and thicker 
temporal cortex only at early age at FEP (before 18–20 
y). The AFP group also had age-constant (12–35-y age 
span) volume enlargements in the frontal and parietal lobe. 
Our study suggests that age at first episode modulates the 
structural brain abnormalities found in FEP patients in a 
nonlinear and diagnosis-dependent manner. Future MRI 
studies should take these results into account when inter-
preting samples with different ages at onset and diagnosis.
Key words:  first-episode psychosis/age at onset/ 
schizophrenia/bipolar disorder/cortical thickness/ 
cortical volume/MRI
Introduction
Brain development during adolescence follows a hetero-
geneous pattern with regions maturing at different rates 
and in a nonlinear fashion.1–4 Consequently, for patients 
with neurodevelopmental disorders, a structural brain 
deficit may be more marked in a compartment under-
going pronounced maturation.4 Thus, when assessing 
the effect of age at first episode of psychosis (FEP) on 
diagnostic brain deficits, a sample comprising the various 
stages of brain maturation is preferred.4
The concept of age at FEP modulating brain deficits is 
exemplified by patients with first-episode schizophrenia 
spectrum disorders (SSD) who show focal parietal deficits 
when onset is in childhood or early-adolescence,5–7 whereas 
late-adolescent or early-adult onset are associated with more 
widespread gray matter (GM) cortical (eg, frontal, temporal, 
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insular) and subcortical volume and/or thickness deficits.8–19 
This pattern has also been reported in patients with first-epi-
sode affective psychoses (AFP), with alterations being larger 
and more widespread in the SSD group.8,12,20–22 Previous 
studies assessing the effect of age at FEP on brain structure 
suggest that earlier onset is associated with greater disrup-
tion of structural brain development.7,23–26 However, inter-
pretation of these results may be hampered by using age as 
a linear variable and disregarding the nonlinear relationship 
of age with brain development,24,26 stratifying cases into sev-
eral onset (adolescent/adult) groups instead of treating age 
as a continuous variable,23,25 and using a narrow age-range 
sample of patients which does not encompass important 
stages of brain development.7 We do not know of a study 
assessing the nonlinear effect of age on brain deficits in FEP 
patients whose first-episode onset ranges from early adoles-
cence through adulthood.
In this study, we scanned a large sample of FEP 
patients with a wide age span (12–35 y) and a sample of 
healthy controls (HC) matched for age, sex, and handed-
ness. We aimed to determine whether age at FEP has a 
nonlinear effect on the diagnostic-related abnormalities 
detected at start of psychosis. Based on the literature, we 
hypothesized that FEP patients would have volume and 
thickness abnormalities in regions undergoing macro-
scopic maturation at each particular stage. Therefore, (1) 
SSD patients with earlier age at FEP would show abnor-
malities in frontal, temporal, and cingulate cortices and 
subcortical regions and (2) AFP patients would have age-
modulated abnormalities in similar regions, with mor-
phometric measures positioned in between HC and SSD.
Methods
Subjects
The sample came from the “Phenotype-genotype and 
environmental interaction. Application of a predictive 
model in first psychotic episodes” study (or PEPs study, 
from its acronym in Spanish), a 2-year, multicenter, natu-
ralistic, prospective study, in which 335 FEP patients and 
253 HC were recruited from January 2009 to December 
2011.27 The patient sample was consecutively recruited 
from several outpatient clinics and inpatient units in Spain. 
Inclusion criteria for patients were: (1) age 7–35 years at 
the time of first evaluation, (2) psychotic disorder accord-
ing to DSM-IV criteria of less than 12 months’ duration, 
(3) speaking Spanish correctly, and (4) written informed 
consent. Exclusion criteria for patients were: (1) mental 
retardation according to DSM-IV criteria,28 (2) history 
of head trauma with loss of consciousness, and (3) sys-
temic disease with mental health impact. A sample of HC 
matched for age, sex, ethnicity, and handedness (in the 
global sample, at each site and across sites) was recruited 
from the same geographic areas as patients. Inclusion 
criteria for HC were the same as for patients, except for 
past or present psychotic symptoms. Exclusion criteria 
were the same as for patients plus (1) past or present psy-
chotic symptoms or major depressive disorder and (2) 
first-degree relative with history of psychotic disorder. 
A complete description of study design and recruitment 
procedures is provided elsewhere.27 A complete descrip-
tion of the assessment procedures is presented as supple-
mentary material 1.
Figure 1 shows the flowchart for study inclusion. Out 
of the 16 sites participating in the PEPs Project,27 11 sites 
participated in the neuroimaging module (PEPs-Img 
study). Subjects were then scanned on 6 scanner plat-
forms (subjects from different sites within the same city 
were scanned on the same machine). To minimize the 
effect of time since FEP onset, we restricted our analy-
sis to patients with less than 18 months’ duration from 
positive psychotic symptom onset to scan acquisition 
(ie, a maximum of 12 months from onset to recruitment 
as per inclusion criteria plus a maximum of 6  months 
from inclusion to scan). A sample of 353 subjects—196 
patients (SSD: n = 92, AFP: n = 32, and other psychoses 
[OP]: n = 72) and 157 HC—was, therefore, included in the 
PEPs-Img study.
The study was approved by the institutional review 
boards of all the participant sites and was conducted 
according to the provisions of the World Medical 
Association Declaration of Helsinki. Written informed 
consent was obtained from all participants and also from 
parents/legal guardians for children under 16 years of age.
Image Acquisition and Analysis
T1-weighted magnetic resonance imaging (MRI) scans 
of the subjects recruited in the PEPs-Img study were 
acquired on 6 scanner platforms. Full details about the 
characteristics of each platform and acquisition proto-
col are provided in supplementary material 2. Scans were 
visually assessed for quality prior to image processing, 
and no scans were deemed of insufficient quality.
Intracranial volume was estimated from skull-stripped 
segmented T1-weighted images obtained using SPM8 
(available at: http://www.fil.ion.ucl.ac.uk/spm) with the 
VBM8 toolbox (available at: http://dbm.neuro.uni-jena.
de/vbm) by summing total GM and white matter (WM) 
and cerebrospinal fluid volumes. Total brain volume 
(TBV) was calculated as the sum of total GM and WM 
volumes. The FreeSurfer analysis suite (v5.3, available 
at: http://surfer.nmr.mgh.harvard.edu/) was used with 
default settings to generate regional volume and corti-
cal thickness measurements29 for each cortical region of 
interest (ROI),30 including (1) lobar ROIs (frontal, pari-
etal, temporal, and occipital); (2) anterior and posterior 
cingulate, middle frontal gyrus, medial orbitofrontal 
cortex, superior and middle temporal gyri, precuneus, 
and insula; and (3) subcortical/ventricular ROIs (lateral 
ventricles; third and fourth ventricle; hippocampus; basal 
ganglia: caudate, putamen, and pallidum; and thalamus). 
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Note that for the subcortical/ventricular ROI group, 
only cortical volume was calculated. All measures were 
summed or averaged over both hemispheres. All segmen-
tations were found to be accurate after visual inspection. 
Processing was supervised by experts with extensive expe-
rience in image processing.8,31
The PEPs-Img Reproducibility Study
An interscanner reproducibility study was performed 
using data from 6 HC scanned at each participating site. 
Full details about the results derived from the compat-
ibility study are presented as supplementary material 2. It 
was decided that: (1) for all morphometric measurements, 
site would be included as a covariate in all analyses, (2) 
only ROIs that showed reasonable reproducibility among 
the 6 scanners (intraclass  correlation coefficient [ICC]all 
sites ≥ 0.7) would be studied, and (3) for ROIs with ICCall 
sites <0.7 but with reasonable reproducibility between sites 
1 and 2 (ICCsites 1–2 ≥ 0.7), analyses would be done only for 
the subsample of patients (n = 131) and controls (n = 111) 
scanned at those sites.
Statistical Analyses
Differences among FEP patients, diagnostic subgroups, 
and HC in demographic data and baseline clinical data 
were assessed by Chi-square, Fisher exact, or ANOVA 
tests as appropriate, after normality of distributions 
and homoscedasticity of variances were checked. Partial 
Spearman rank correlations, t tests, or ANOVA tests were 
used to investigate the relationships of demographic and 
clinical variables with each morphometric measurement. 
Sex, parental socioeconomic status (SES), and estimated 
intelligence quotient (IQ) were found to show significant 
associations with most morphometric measurements.
First, nonparametric statistical procedures were used to 
assess the nonlinear relationship of age with morphomet-
ric measurements. Volume and thickness measurements 
were corrected by site, sex, SES, estimated IQ, and TBV 
(volume measurements only), and standardized residu-
als were saved. Using nonparametric kernel-smoothing 
procedures, saved residuals (“y”) were depicted as a func-
tion of age at scan (“x”) for 3 diagnostic pairs (SSD vs 
HC, AFP vs HC, and SSD vs AFP). The OP group was 
excluded from this analysis due to its reportedly high 
diagnostic instability, both in pediatric32 and adult FEP 
patients33 (figure 1, analysis 1). Bootstrapping procedures 
were used to compute 95% CIs for each of the measure-
ments. To do so, 10 000 samples were generated and all 
the curves were computed in each sample. Each point of 
the bound curves was estimated with the appropriate per-
centile (2.5 for lower bound and 97.5 for upper bound). 
Fig. 1. Flowchart for inclusion in the PEPs-Img study. AFP, 12-month follow-up diagnosis of affective psychosis (type I bipolar 
disorder or major depressive disorder with psychotic symptoms); HC, healthy controls; ICC, intraclass correlation coefficient; MRI, 
magnetic resonance imaging; OP, 12-month follow-up diagnosis of other psychotic disorder (brief  reactive psychosis, delusional disorder, 
substance-induced psychotic disorder, or psychotic disorder not otherwise specified); PEPs, “first psychotic episode” study; PEPs-Img, 
PEPs imaging study; SSD, 12-month follow-up diagnosis of schizophrenia spectrum disorder (schizophrenia, schizophreniform, or 
schizoaffective disorder).
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Nadaraya-Watson kernel regression estimates were used. 
The kernel function was Gaussian and to choose the 
appropriate degree of smoothness, bandwidth parame-
ters were established using Silverman’s rule of thumb.34,35 
These analyses were performed using R package “mon-
reg” (version 0.1.3).36 To assess if  and when curves dif-
fered significantly between groups, the age at CI overlap 
was determined by visual inspection.
Secondly, to assess the age (“x”) when between-group 
differences became statistically significant, cases were 
stratified into “early-onset” and “late-onset” groups at 
age points where curves showed CI crossover, ie, subjects 
≤ 15 vs > 15 years; subjects < 18 vs ≥ 18 years, and sub-
jects < 20 vs ≥ 20 years, depending on the curve (figure 1, 
analysis 2). Separate ANCOVA were conducted for each 
“early-onset” and “late-onset” diagnostic pair. Volume 
and thickness measurements were corrected by sex, SES, 
estimated IQ, and TBV (volume measurements only), 
and standardized residuals were saved. ANCOVA were 
performed with age and site as covariates. The signifi-
cance threshold was set as P <.05. The Bonferroni correc-
tion for multiple comparisons was applied. For variables 
that reached significance, effect sizes (Cohen’s d) were 
calculated.37 These analyses were performed using SPSS 
(v.18.0).
Thirdly, using the above procedure, diagnostic-group 
differences were calculated with ANCOVA for the whole 
sample, with age as a linear covariate (figure 1, analysis 
3). This was done to test whether nonlinear procedures 
reveal details not apparent using linear multivariate 
analyses.
Results
Demographic and clinical characteristics of the 196 
patients and 157 controls included in the PEPs-Img study 
are presented in table 1. Demographic and clinical char-
acteristics of the 131 patients and 111 controls scanned at 
sites 1 and 2 are presented in table 2. The ratio of patients 
(and diagnostic subgroups) and controls scanned at each 
site is presented as supplementary material 3.
Nonlinear effects of age results are shown in figures 
2a–c, 3a, and 3b where depicted residuals and CI for 
volume and thickness measurements (“y”) as a function 
of age at scan (“x”) for each diagnostic pair are given. 
Where appropriate, significant diagnosis-related differ-
ences between early-onset groups using ANCOVA are 
shown. Note that in all group comparisons, the sample 
size of the younger group was smaller, and the effect sizes 
of the significant group differences were medium to large, 
according to Cohen’s criteria.37
SSD vs HC
Earlier age at first-episode SSD cases had smaller fron-
tal lobe, caudal middle frontal gyrus, and temporal lobe 
volumes (figures 2a and 2b) as well as larger third ven-
tricle, caudate, putamen, and lateral ventricle volumes 
(figure  2c). They also had thinner frontal, medial orbi-
tofrontal, and insular cortices (figures 3a and 3b). SSD 
cases and HC followed a similar downward pattern in 
parietal and occipital volumes (figure  2a) and in thick-
ness of ROIs such as parietal or temporal lobe or poste-
rior cingulate (figures 3a and 3b) across the age span of 
12–35 years.
AFP vs HC
Earlier age at first-episode AFP cases had smaller cau-
dal anterior cingulate; larger caudate, putamen, third 
ventricle, and lateral ventricle volumes (figures 2b and 
2c); and thicker temporal and occipital lobes (figure 3a). 
The AFP group also displayed age-constant (12–35-y age 
span) volume enlargements and/or cortical thickening in 
frontal and parietal lobes (figures 2a and 3a).
SSD vs AFP
Earlier age at first-episode SSD patients had significantly 
smaller frontal volumes (figure 2a) and thinner frontal, 
temporal, parietal, medial orbitofrontal, and insular cor-
tices (figures 3a and 3b) than AFP patients. SSD patients 
also had smaller middle frontal gyrus volumes and thin-
ner precuneus cortices throughout the 12–35-years age 
span (figures 2b and 3b). Besides, both groups showed 
age-constant (12–35 y) volume deficits in parietal and 
occipital lobes (figure 2a) as well as in the caudate and 
putamen (figure 2c).
Between-group differences in volume and thickness 
measurements residuals for the whole sample using 
ANCOVA are provided in supplementary material 4.
Discussion
This study covering a wide age span (12–35 y) supports 
our hypothesis that age at first psychotic episode modu-
lates the structural brain abnormalities found in patients 
with FEP in a nonlinear and diagnosis-dependent man-
ner. Specifically, patients with SSD and earlier (but not 
later) age at FEP (around 15–20 y) showed significant 
volume enlargements in ventricular system and basal 
ganglia compared to controls, volume and thickness defi-
cits in frontal lobe, and volume deficits in temporal lobe 
compared to patients with AFP and controls. Similarly, 
first-episode AFP patients had smaller cingulate cortex 
volume and thicker temporal cortex only at early ages. 
Other regions (eg, frontal and parietal lobes) showed 
age-constant group differences across the 12–35-years 
age span, enlarged in volume in AFP patients relative to 
controls. Our results indicate that MRI studies in FEP 
should take into account the nonlinear effect of age on 
brain structure when interpreting samples with different 
age at FEP and diagnosis.
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T
ab
le
 1
. 
C
on
ti
nu
ed
To the best of  our knowledge, this is the first study 
assessing the nonlinear association of  age at first 
episode and structural brain abnormalities in FEP 
patients whose onset ranges from early adolescence 
through adulthood. Our results may be interpreted in 
the context of  what is known about the heterogeneity 
of  typical brain maturity, ie, different structures mature 
at different ages and rates.1–4,38 We and others postulate 
that if  onset of  psychosis coincides with active matura-
tional changes in a brain structure, then development of 
that particular brain structure will be most affected by 
the disease.4,22 The current study indicates that if  SSD 
starts after early adolescence, no differences are found 
in the parietal cortex of  cases and controls. The parietal 
cortex reaches peak maturity in late childhood (around 
7.5 y in girls and 9 in boys4), and parietal abnormali-
ties are present in very early-onset psychosis such as 
childhood-onset schizophrenia.5,6 The frontal and tem-
poral cortices mature later during adolescence,4 and 
onset of  psychosis during this developmental period 
has been shown to principally affect frontal and tem-
poral regions,8–11 as was the case with the SSD group in 
the current study.
Contrary to our expectations, brain morphometric 
measurements in AFP were not positioned in between 
healthy individuals and SSD.39 AFP cases showed larger 
volume and/or thickness measurements in frontal, tem-
poral, and parietal lobe compared to the other groups 
and smaller cingulate cortex volume in earlier onset AFP 
patients (as expected) relative to controls. Some studies 
have not found any differences between first-episode SSD 
and AFP patients, and many others do not include diag-
nostic subgroup comparisons.22 Hence this finding war-
rants further replication. A previous study in first-episode 
AFP and schizophrenia patients aged 18–40  years also 
showed brain deficits confined to the subgenual cingulate 
in this specific subgroup.40 This result is of special inter-
est, as this region has been recently proposed as key in 
affective symptoms.41,42
Our study found larger caudate and putamen volumes 
in adolescent- and early-adult-onset psychosis patients, 
a period at which there is active area expansion in typi-
cally developing subjects.43 Hippocampal volume deficits 
have been shown in both AFP and SSD patients,44 but 
more strongly linked to SSD45 and later-onset cases.26,46 In 
this study, nonparametric procedures did not show any 
diagnosis-related difference in the hippocampus across 
the age span.
Our findings provide an interpretation for divergent 
brain abnormalities previously reported for earlier- and 
later-onset FEP patients. The results also warrant cau-
tion when using age at first episode as a categorical dis-
criminant factor for comparing FEP patients, especially 
when patients with positive psychotic symptom onset 
under and over 20 years are included in the same study. 
The meaning of these deficits and their correlates at a 
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Fig. 2. Differences between diagnostic groups in volume measurements (“y”) as a function of age at scan (“x”). Standardized 
residuals after controlling for total brain volume, site, sex, parental socioeconomic status, and estimated intelligence quotient (y axis) 
as a function of age at scan (x axis). AFP, affective psychosis; GM, gray matter; HC, healthy controls, ROI, region of interest; SSD, 
schizophrenia spectrum disorder. (2a) Note: ICCall sites ≥ 0.8 for all lobar ROIs except for occipital lobe (ICCsites 1–2 ≥ 0.9). *
A <20 y SSD < 
HC (F1, 66 = 4.66, P = .04, d = 0.532). *
B <20 y SSD < HC (F1, 66 = 4.81, P = .03, d = 0.549). *
C <20 y SSD < AFP (F1, 30 = 5.41, P = .03, 
d = 0.850). (2b) Note: ICCall sites ≥ 0.9 for all cortical ROIs except for medial orbitofrontal cortex (ICCsites 1–2 ≥ 0.7). *
D <20 y AFP < HC 
(F1, 113 = 5.41, P = .02, d = 0.644). (2c) Note: ICCall sites ≥ 0.7 for third ventricle, ICCall sites ≥ 0.9 for lateral ventricles, caudate, and putamen. 
*E <20 y SSD > HC (F1, 66 = 4.34, P = .04, d = 0.154). *
F <20 y AFP > HC (F1, 113 = 5.79, P = .02, d = 0.667). *
G <20 y AFP > HC (F1, 
113 = 7.32, P = .009, d = 0.749). *
H <20 y AFP > HC (F1, 113 = 4.12, P = .05, d = 0.565.
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cellular level, and if  and how they affect clinical pheno-
type and course of illness, are not yet understood, war-
ranting further study.47
Our study also indicates that using linear statisti-
cal approaches to assess the effect of age on diagnosis-
related brain abnormalities leads to finding no or much 
less marked differences among diagnostic groups. This 
was clearly the case in our ANCOVA (supplementary 
material 4) despite using a large sample and carefully 
handling potential confounders. In our study, although 
acknowledging the problem with age strata, separate 
ANCOVA showed that some (but not all) diagnosis-
related abnormalities in FEP patients are evident for only 
“early-onset” groups. This was true even when there was 
a higher probability of type II errors due to decreased 
subgroup sample sizes.
Results derived from this study should be interpreted 
in the context of  several limitations. Firstly, in this 
study “age at psychosis onset” was made comparable 
to “age at scan” and patients were scanned around the 
time of  onset of  positive psychotic symptoms. Onset 
of  positive symptoms may not reflect the actual psy-
chotic onset itself  and cognitive/negative symptoms 
are hard to assess accurately using retrospective assess-
ments. There may be a possibility that patients with 
early cognitive impairment have less resilience and 
therefore manifest reality distortion (ie, a psychotic 
episode) earlier such that detected brain abnormalities 
are actually more related to a psychopathology domain 
than to the onset of  psychosis. We cannot rule out this 
possibility with the current study design. Furthermore, 
there is a possibility that reported brain abnormali-
ties may, to some extent, represent the effect of  both 
emergence and progression of  psychosis over the ini-
tial months of  the psychotic break.48 However, age at 
scan is an objective and reliable measure, as this is a 
relatively recent-onset sample (mean time since first 
positive symptoms = 151.94 d) and no significant asso-
ciations were found between time since first psychotic 
symptoms or any of  the morphometric measurements 
under study. Secondly, we used 12-month follow-up 
diagnosis to categorize patients into psychosis sub-
groups, but diagnosis could change over time.32,33,49 Yet, 
the OP group was not included in the nonparametric 
analysis. Thirdly, there was considerable interindividual 
variability in morphometric measurements, as reflected 
in the wide CI of  the curves, which was more marked 
in some regions and groups (temporal lobe; affective 
patients). This variance may decrease the probability of 
detecting group differences. Fourthly, SSD and younger 
patients had greater symptom severity, allowing for the 
possibility that psychopathology modulate brain mor-
phology.50 This warrants caution when interpreting our 
results. Fifthly, both antipsychotics15,51 and lithium52,53 
have been reported to be potential confounders of  the 
brain abnormalities found in FEP patients. However, 
treatment duration in our sample was relatively short 
(mean of  80.6 d of  antipsychotic exposure and 18.8 
d of  lithium exposure). Sixthly, despite the use of  site 
as a covariate and despite conducting a reproducibil-
ity study beforehand, it is difficult to argue that the 
effect of  site is fully controlled for, so results need to 
be interpreted with caution. Seventhly, as the PEPs was 
an observational study, the effect of  other potentially 
relevant confounders that may affect brain structure 
was not assessed (eg, pubertal status). Finally, although 
Fig. 2. Continued
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we corrected for the number of  group comparisons, we 
did not apply any formal correction for the number of 
variables tested, because of  the type of  nonparametric 
procedure used and as the study was exploratory (ie, 
assessing whether different ages at FEP affect the dif-
ferences in brain structure between cases and controls 
Fig. 3. Differences between diagnostic groups in cortical thickness measurements (“y”) as a function of age at scan (“x”). Standardized 
residuals after controlling for site, sex, parental socioeconomic status, and estimated intelligence quotient (y axis) as a function of age at scan 
(x axis). AFP, affective psychosis; HC, healthy controls; ROI, region of interest; SSD: schizophrenia spectrum disorder. (3a) Note: ICCall sites ≥ 
0.7 for temporal and occipital lobes, ICCsites 1–2 ≥ 0.7 for frontal lobe, ICCsites 1–2 ≥ 0.8 for parietal lobe. *
A ≤15 y SSD < HC (F1, 12 = 5.14, P = .04, 
d = 1.309). *B <20 y AFP > HC (F1, 43 = 6.04, P = .02, d = 0.749). *
C <18 y AFP > HC (F1, 22 = 5.35, P = .03, d = 0.987). *
D <20 y AFP > HC 
(F1, 43 = 5.84, P = .02, d = 0.739). *
E <18 y AFP > HC (F1, 22 = 12.6, P = .002, d = 1.513). *
F ≤15 y SSD < AFP (F1, 5 = 8.78, P = .03, d = 2.649). 
*G <20 y SSD < AFP (F1, 30 = 6.96, P = .01, d = 0.962). *
H <20 y SSD < AFP (F1, 27 = 7.21, P = .01, d = 1.034). *
I <18 y SSD < AFP (F1, 
22 = 6.09, P = .02, d = 1.503). (3b) Note: ICCall sites ≥ 0.7 for all ROIs. *
J <18 y AFP > HC (F1, 22 = 5.31, P = .03, d = 0.981). *
K ≤15 y SSD < 
AFP (F1, 5 = 8.09, P = .04, d = 2.544). *
L <20 y SSD < AFP (F1, 30 = 4.24, P = .048, d = 0.753).
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rather than confirming an a priori hypothesis),54,55 and 
variables were not independent.
The main strengths of this study include the use of 
a nonparametric statistical approach and the large age 
span of the sample, the use of a large patient sample with 
recent FEP onset, the careful patient-control matching 
strategy and handling of potential confounders; and the 
reproducibility study conducted beforehand.
In summary, our study supports that age at first epi-
sode determines the type of morphological deficits found 
in FEP patients in a nonlinear and diagnosis-specific 
manner. This highlights the need for studies that take 
into account the nonlinear effect of age when interpret-
ing structural brain deficits in wide age-range samples. In 
addition, our study reflects how the brain is differently 
affected in psychosis patients depending on maturational 
stage, particularly when still undergoing major develop-
mental changes, and highlights the need for longitudinal 
studies to further assess abnormal brain developmental 
trajectories from the very early stages and throughout the 
illness.
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